International Tumor Board Explores Personalized Treatment Options for Glioblastoma With MDM2 and EGFR Amplifications
8:42
BUFFALO, NY – October 22, 2026 – A new #case report was #published in Volume 17 of Oncotarget on October 16, 2026, titled “Case Report WIN-MTB-2024001 – WIN International Molecular Tumor Board: A 55-year-old male with glioblastoma exhibiting amplifications in MDM2 and EGFR.” The report describes the clinical journey of a 55-year-old man diagnosed with glioblastoma (GBM), an aggressive brain…